Director Commercial Strategy & Growth - LATAM

Dexcom Corporation (NASDAQ DXCM) is a pioneer and global leader in continuous glucose monitoring (CGM). Dexcom began as a small company with a big dream:
To forever change how diabetes is managed. To unlock information and insights that drive better health outcomes. Here we are 25 years later, having pioneered an industry. And we're just getting started. We are broadening our vision beyond diabetes to empower people to take control of health. That means personalized, actionable insights aimed at solving important health challenges. To continue what we've started:
Improving human health.

Join our dynamic and innovative Dexcom team! We are dedicated to empowering individuals to take control of their health and well-being through cutting-edge biosensor technology and intuitive app experiences. If you're passionate about pushing the boundaries of what's possible and thrive in fast-moving environments, we want you on our team. Together, we create solutions that make a positive impact on people's lives.

Dexcom Canada is seeking a Director, Commercial Strategy and Growth to lead business case development, commercialization efforts, and go-to-market strategy for expanding the Dexcom’s product portfolio into LATIN AMERICA. If you thrive in cross-cultural environments and are passionate about scaling impactful technology, we want you on our team. This is an enterprise mandate that will be accountable to Dexcom’s General Manager for CANADA & Latinn America.

• Business Case Development:
  Develop and own the business case for Dexcom’s product expansion, including market opportunity sizing, financial projections, and regulatory considerations. Present data-driven justifications for investment, outlining revenue forecasts and ROI for the LATAM market entry. Success depends on the capability to forecast accurately, mitigate risks, and influence cross‑functional stakeholders using data‑driven rationale.
• Market Research & Positioning:
  Drive LATAM market research and competitive analysis to inform product positioning and strategy. Analyze the LATAM diabetes and consumer health wearable technology landscape – customer needs, competitor offerings, reimbursement and regulatory environment – and use these insights to shape Dexcom’s market entry approach (messaging, differentiation, pricing)
• Stakeholder Alignment:
  Build and nurture strong relationships with external LATAM stakeholders as well as global and regional DEXCOM stakeholders (e.g. Dexcom’s global product teams, regional commercial leaders, and external partners). Ensure ongoing alignment on priorities, timelines, and success metrics for the LATAM launch. Facilitate regular updates and governance meetings to keep executives informed of GTM readiness, risks, and needs for support.
• Go-to-Market Strategy:
  Create the go-to-market (GTM) strategy for the LATAM launches, partnering with global marketing, regulatory, and commercial teams to ensure alignment with local and global plans. Define launch objectives, market segmentation, distribution plans and value propositions tailored to Canadian customers and healthcare stakeholders.
• Pricing & Commercial Strategy:
  Develop LATAM-specific pricing and commercial models in collaboration with global teams. Recommend pricing structures and reimbursement strategies that balance market penetration with Dexcom’s financial objectives.
• Financial Acumen:
  Demonstrate financial literacy, including the ability to interpret key performance drivers, manage budgets, and optimize profitability through disciplined P&L oversight. Strategic decision‑making grounded in long-range financial insight is required to guide resource allocation, assess investment trade‑offs, and ensure sustainable…